These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9822217)

  • 1. Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: evaluation of discordant findings.
    Stierer M; Rosen H; Weber R; Hanak H; Auerbach L; Spona J; Tüchler H
    Breast Cancer Res Treat; 1998 Jul; 50(2):125-34. PubMed ID: 9822217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.
    Stierer M; Rosen H; Weber R; Hanak H; Spona J; Tüchler H
    Ann Surg; 1993 Jul; 218(1):13-21. PubMed ID: 8328824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
    Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
    Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.
    Reiner A; Neumeister B; Spona J; Reiner G; Schemper M; Jakesz R
    Cancer Res; 1990 Nov; 50(21):7057-61. PubMed ID: 2208173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma].
    Simone G; Paradiso A; Cirillo R; Mangia A; Rella G; Wiesel S; Petroni S; De Benedictis G; De Lena M
    Pathologica; 1991; 83(1086):449-59. PubMed ID: 1724316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival.
    Pertschuk LP; Kim DS; Nayer K; Feldman JG; Eisenberg KB; Carter AC; Rong ZT; Thelmo WL; Fleisher J; Greene GL
    Cancer; 1990 Oct; 66(8):1663-70. PubMed ID: 2208020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.
    Alberts SR; Ingle JN; Roche PR; Cha SS; Wold LE; Farr GH; Krook JE; Wieand HS
    Cancer; 1996 Aug; 78(4):764-72. PubMed ID: 8756370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
    Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
    Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer--clinical associations and reasons for discrepancies.
    Chebil G; Bendahl PO; Idvall I; Fernö M
    Acta Oncol; 2003; 42(7):719-25. PubMed ID: 14690157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
    Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
    BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the biochemical and immunohistochemical determination of hormone receptors in invasive breast carcinoma influence of the tumor-stroma ratio.
    Van den Eynden GG; Colpaert CG; Vermeulen PB; Weyler JJ; Goovaerts G; van Dam P; Van Marck EA; Dirix LY
    Pathol Res Pract; 2002; 198(8):517-24. PubMed ID: 12389994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
    Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
    Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between low estrogen receptor values and other prognostic factors in primary breast tumors.
    Gaffney EV; Halpin DP; Blakemore WS
    Surgery; 1995 Mar; 117(3):241-6. PubMed ID: 7878527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
    Redkar AA; Kabre SS; Mittra I
    Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors.
    Nakamura R; Yamamoto N; Shiina N; Miyaki T; Ikebe D; Itami M; Shida T; Miyazaki M
    Breast; 2016 Apr; 26():141-7. PubMed ID: 26732051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance and discordance of estrogen and progesterone receptor content in sequential biopsies of patients with advanced breast cancer: relation to survival.
    Raemaekers JM; Beex LV; Koenders AJ; Pieters GF; Smals AG; Benraad TJ; Kloppenborg PW
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1011-8. PubMed ID: 6540683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance.
    Allred DC; Bustamante MA; Daniel CO; Gaskill HV; Cruz AB
    Arch Surg; 1990 Jan; 125(1):107-13. PubMed ID: 1688490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and progesterone receptors in human meningiomas: biochemical and immunocytochemical evaluation.
    Bozzetti C; Camisa R; Nizzoli R; Manotti L; Guazzi A; Naldi N; Mazza S; Nizzoli V; Cocconi G
    Surg Neurol; 1995 Mar; 43(3):230-3; discussion 234. PubMed ID: 7792684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
    Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.